These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37467878)

  • 21. Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.
    Gupta R; Bollyky TJ; Cohen M; Ross JS; Kesselheim AS
    BMJ; 2018 Mar; 360():k831. PubMed ID: 29555641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The timing of 30-month stay expirations and generic entry: A cohort study of first generics, 2013-2020.
    Kannappan S; Darrow JJ; Kesselheim AS; Beall RF
    Clin Transl Sci; 2021 Sep; 14(5):1917-1923. PubMed ID: 33982425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scientific considerations in the review and approval of generic enoxaparin in the United States.
    Lee S; Raw A; Yu L; Lionberger R; Ya N; Verthelyi D; Rosenberg A; Kozlowski S; Webber K; Woodcock J
    Nat Biotechnol; 2013 Mar; 31(3):220-6. PubMed ID: 23471071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation-Updated Consensus and Review 2020.
    Jawa V; Terry F; Gokemeijer J; Mitra-Kaushik S; Roberts BJ; Tourdot S; De Groot AS
    Front Immunol; 2020; 11():1301. PubMed ID: 32695107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin.
    Lambert PA; Conway BR
    J Chemother; 2003 Aug; 15(4):357-68. PubMed ID: 12962364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteers.
    Bergmann F; Wulkersdorfer B; Oesterreicher Z; Bauer M; Al Jalali V; Nussbaumer-Pröll A; Wölfl-Duchek M; Jorda A; Lackner E; Reiter B; Stimpfl T; Ballarini N; König F; Zeitlinger M
    J Antimicrob Chemother; 2022 Oct; 77(11):3086-3092. PubMed ID: 36039038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of structurally related peptide impurities using HPLC-QTOF-MS/MS: application to Cbf-14, a novel antimicrobial peptide.
    Huo Y; Xu K; Lu Y; Ma L; Zhou C; Hang T; Song M
    Anal Bioanal Chem; 2022 Sep; 414(22):6485-6495. PubMed ID: 35840670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspects of complexity in quality and safety assessment of peptide therapeutics and peptide-related impurities. A regulatory perspective.
    Colalto C
    Regul Toxicol Pharmacol; 2024 Nov; 153():105699. PubMed ID: 39243929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex Generic Products: Insight of Current Regulatory Frameworks in US, EU and Canada and the Need of Harmonisation.
    Lunawat S; Bhat K
    Ther Innov Regul Sci; 2020 Sep; 54(5):991-1000. PubMed ID: 31960290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
    Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
    Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of impurity profiles of Orlistat pharmaceutical products using HPLC tandem mass spectrometry.
    Schneider A; Wessjohann LA
    J Pharm Biomed Anal; 2010 Nov; 53(3):767-72. PubMed ID: 20570457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs.
    Hottinger M; Liang BA
    Am J Law Med; 2012; 38(4):667-89. PubMed ID: 23356099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovation strategies for generic drug companies: moving into supergenerics.
    Ross MS
    IDrugs; 2010 Apr; 13(4):243-7. PubMed ID: 20373253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abbreviated New Drug Applications: Generic Drug User Fee Amendments Act Analysis of Application Quality Metrics.
    Woo J; Luan JJ; Li Z; Grosser S; Peters J; Chazin H
    Ther Innov Regul Sci; 2019 Sep; 53(5):696-700. PubMed ID: 30360656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low quality of some generic cardiovascular medicinal products represents a matter for growing concern.
    Tamargo J; Rosano G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):176-187. PubMed ID: 31501855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Level A Type IVIVC for the Rational Design of Clinical Trials Toward Regulatory Approval of Generic Polymeric Long-Acting Injectables.
    Somayaji MR; Das D; Przekwas A
    Clin Pharmacokinet; 2016 Oct; 55(10):1179-1190. PubMed ID: 27349905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impurities in generic pharmaceutical development.
    Kovaleski J; Kraut B; Mattiuz A; Giangiulio M; Brobst G; Cagno W; Kulkarni P; Rauch T
    Adv Drug Deliv Rev; 2007 Jan; 59(1):56-63. PubMed ID: 17196702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generic Medicines in Croatia--Regulatory Aspects and Statistics.
    Zulfikari S; Sučić AF; Meštrović K; Barbarić MP; Mandarić V; Zorić N; Tomić S
    Coll Antropol; 2015 Jun; 39(2):363-70. PubMed ID: 26753452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube Administration.
    Ren P; Cui M; Anand O; Xia L; Zhao ZJ; Sun D; Sharp T; Conner DP; Peters J; Jiang W; Stier E; Jiang X
    AAPS J; 2017 Nov; 19(6):1593-1599. PubMed ID: 28879628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.